Therapeutic Antibodies – News and Features
News
MorphoSys and Boehringer Ingelheim Expand Collaboration with Cancer-Related Antibody Program
MorphoSys will optimize the antibody in accordance with the requirements of the partner and will receive additional research payments.
News
Medarex and PacMab Announce Therapeutic Antibody Co-Development Agreement
Companies intend to use Medarex's UltiMAb Human Antibody Development System® to generate fully human antibodies.
News
Lpath Collaborates with Sapient Discovery
Companies collaborate to characterize favorable interactions of Lpath's Anti-S1P therapeutic antibody with its target.
News
Dyax and ZymoGenetics Enter Into Library License Agreement
Companies announce agreement for discovery of therapeutic antibodies.
News
Researchers Describe Gene’s Role in Breast Cancer
Analysis of breast-cancer gene role offers promising target for drugs to stop or slow progression of the disease.
News
CAT and MSM Enter Drug Discovery Collaboration
Collaboration aimed at developing antibody-based drugs targeting multi-spanning membrane proteins.
News
Morphotek Raises $40 Million to Advance Its Antibody Pipeline
The funds will be used primarily to further clinical development of the Company's lead therapeutic antibodies.
News
Lumera Signs Agreement with Institute for Systems Biology to Address Cancer Detection
Extended partnership to focus on developing methods with the ProteomicProcessor™ for cancer biomarker detection.
News
Pepscan Secures Euro 7 Million in its Second Financing Round
Company also launches its phase I/II GNRH vaccine trial for the treatment of hormone dependant prostate cancer.
News
Lumera Scientist Previews Company's Therapeutic Antibody Drug Discovery Products
The presentation detailed the analysis of a high density antibody microarray for potential drug discovery "hits" to the cancer antigen.
Advertisement
